Physician profile
Injoon Lee
NPI 1508251265
$5,282.23
in general payments reported to CMS, 2019-2025
28 companies · $1,919 in 2025
The $1,919 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $162 · 2021: $699 · 2022: $403 · 2023: $795 · 2024: $1,098 · 2025: $1,919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,287 · Travel and Lodging: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,286.63 |
| Travel and Lodging | $525.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $981.64 | 2020-2025 | Impella |
| Boston Scientific Corporation | $803.81 | 2019-2025 | General - Vascular Access, Avvigo Guidance System, Emblem Mri S-Icd |
| Medtronic, INC. | $700.59 | 2021-2025 | Linq II, In.Pact Admiral, Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $443.56 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $412.34 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $310.91 | 2021-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $264.88 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $244.21 | 2022-2025 | Farxiga, Lokelma |
| Abbott Laboratories | $215.53 | 2021-2025 | Jot Dx, Cardiomems, Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $167.06 | 2019-2025 | Jardiance |
| Pfizer INC. | $113.96 | 2024-2025 | |
| Philips North America LLC | $98.56 | 2024 | (Ck4) Mcot, (Ck7) Extended Holter |
| Inari Medical, INC. | $82.71 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lexicon Pharmaceuticals, INC. | $68.33 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $66.08 | 2022-2024 | Xarelto |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $60.13 | 2025 | Verquvo, Capvaxive |
| Silk Road Medical, INC. | $42.82 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Becton, Dickinson and Company | $24.69 | 2024 | Site-Rite |
| Kiniksa Pharmaceuticals International, Plc | $23.32 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $22.74 | 2024 | Inspire |
| Atricure, INC. | $21.65 | 2023 | |
| Baxter Healthcare | $19.73 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $17.24 | 2023 | Arcalyst |
| Recor Medical INC | $16.08 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cleerly, INC. | $15.74 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Esperion Therapeutics, INC. | $15.54 | 2024 | Nexletol |
| Amgen INC. | $14.94 | 2025 | Repatha |
| Novo Nordisk INC | $13.44 | 2024 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Injoon Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.